Regulatory product record
KOPPER KARE LIQ 37.5%
Approved veterinary drugDPD species: Dog
Product identity, ingredients and source provenance from the regulatory catalogue. Linked clinical evidence has a separate review status.
Product identity
- Brand name
- KOPPER KARE LIQ 37.5%
- DIN
- 00603481
- DPD drug code
- 5922
- Regulatory category
- APPROVED_VET_DRUG
- Market status
- MARKETED
- Route(s)
- TOPICAL
- Pharmaceutical form(s)
- LIQUID
- Ingredients
- COPPER NAPHTHENATE (37.5 %)
- Species (DPD record)
- DOGS
- Company
- DOMINION VETERINARY LABORATORIES LTD. (DIN owner)
Source and provenance
- Source dataset
- health_canada_dpd_marketed
- Source snapshot date
- Not available in this source
- Source record key
- 5922
- Archive fingerprint (SHA-256)
- 85cc3ce208af3aa57018c3d14d83f90220c436baef7455384b6d48d9774e1c88
Linked clinical reference
Clinical entries are linked through the active molecule. Check their species, formulation, source and review status separately from this product record.
Clinical evidence
Dose regimens0
No dose regimens recorded for this species selection.
Adverse effects34
These are counts of spontaneously reported events, not proven adverse effects, causal relationships, or incidence rates.
Bars compare report counts within each species; they do not show incidence.
More reportsFewer reportsDog
- Accidental exposure10 reports
- No sign5 reports
- Vomiting5 reports
- Hypersalivation3 reports
- Abdominal pain2 reports
- Depression2 reports
- Lethargy (see also Central nervous system depression in 'Neurological')2 reports
- Abnormal breathing1 reports
- Abnormal stool colouration1 reports
- Application site pain1 reports
- Ataxia1 reports
- Behavioural disorder NOS1 reports
Cat
- Accidental exposure5 reports
- No sign3 reports
- Anorexia1 reports
- Death by euthanasia1 reports
- Depression1 reports
- Haemorrhage NOS1 reports
- Hypothermia1 reports
- Polyuria1 reports
- Renal failure1 reports
- Vomiting1 reports
Sources: openFDA, U.S. Food and Drug Administration.